Archives
- 2026-09
- 2026-08
- 2026-07
- 2026-06
- 2026-05
- 2026-04
- 2026-03
- 2026-02
- 2026-01
- 2025-12
- 2025-11
- 2025-10
- 2025-09
- 2025-03
- 2025-02
- 2025-01
- 2024-12
- 2024-11
- 2024-10
- 2024-09
- 2024-08
- 2024-07
- 2024-06
- 2024-05
- 2024-04
- 2024-03
- 2024-02
- 2024-01
- 2023-12
- 2023-11
- 2023-10
- 2023-09
- 2023-08
- 2023-07
- 2023-06
- 2023-05
- 2023-04
- 2023-03
- 2023-02
- 2023-01
- 2022-12
- 2022-11
- 2022-10
- 2022-09
- 2022-08
- 2022-07
- 2022-06
- 2022-05
- 2022-04
- 2022-03
- 2022-02
- 2022-01
-
Tropisetron Hydrochloride Assay Workflows
2026-09-03
Tropisetron Hydrochloride supports receptor pharmacology, serotonin pathway studies, and transporter-focused renal assays in one adaptable workflow. This guide translates published OCT2/MATE1 findings into practical experiment design, controls, and troubleshooting steps for reliable in vitro data.
-
Thymoquinone Protects Against Doxorubicin Cardiotoxicity
2026-09-02
A 2025 Toxicology and Applied Pharmacology study identifies thymoquinone as a preclinical cardioprotective agent in a doxorubicin-treated mouse model. Its findings connect improved cardiac function with Nrf2/HO-1 activation, stronger antioxidant defenses, preserved mitochondria, and reduced ferroptosis-related injury.
-
6-FAM SE: Practical Fluorescent Labeling Workflows
2026-09-02
6-FAM SE combines amine-selective coupling with durable fluorescent conjugates for DNA, protein, peptide, and nanoparticle assay development. This guide turns the reagent into a practical workflow, from DMSO stock preparation and labeling to purification, quantitative QC, and careful translation into MOF-based nanomedicine studies.
-
MG-132 in Proteasome, Apoptosis, and HCMV Assays
2026-09-01
MG-132, also known as Z-LLL-al, provides a cell-permeable way to connect proteasome activity with protein turnover, apoptosis, ROS, and cell-cycle phenotypes. This workflow also shows how it can be used cautiously to test whether HCMV UL88-associated MyD88 loss is sensitive to proteasome blockade.
-
MMP-2-Responsive Liposome for Sequential Immunotherapy
2026-09-01
The reference study develops NLG919@Lip-pep1, an MMP-2-responsive liposome designed to deliver the PD-1 pathway-blocking peptide AUNP-12 before exposing a second tumor-targeting module carrying the IDO inhibitor NLG919. Its cascade-targeting strategy combines checkpoint inhibition with immunosuppressive microenvironment remodeling and improves antitumor activity in breast cancer models, while highlighting important requirements for translational nanomedicine.
-
O-GlcNAc, HUWE1, and Ferroptosis in Preeclampsia
2026-08-31
This study identifies an O-GlcNAc–HUWE1–TfR1 pathway that links trophoblast protein modification to iron handling, ferroptosis, and syncytialization defects in preeclampsia. Its combination of placental analyses, O-GlcNAc modification proteomics, mechanistic validation, and mouse experiments provides a framework for examining how altered nutrient-sensitive signaling affects placental disease.
-
Cyclic di-GMP as an Antitoxin in Biofilm Persistence
2026-08-31
Liao et al. identify cyclic di-GMP as a small-molecule antitoxin that restrains the genotoxic toxin HipH during biofilm development. Their findings connect adhesion-stage signaling with DNA double-strand breaks, genome instability, and antibiotic persistence, providing a mechanistic framework for studying biofilm resilience.
-
A40926: From Biosynthetic Control to Assay Insight
2026-08-30
A40926 is a dalbavancin precursor with value beyond conventional antibacterial screening. This article connects its cell-wall mechanism and pathogen-specific MIC behavior with new evidence on pathway-specific regulatory genes, enabling more informed assay and fermentation decisions.
-
RG108: A Practical Guide to DNMT Assays
2026-08-29
RG108 is a non-nucleosidic DNA methyltransferase inhibitor for studying DNA demethylation, tumor suppressor gene reactivation, and epigenetic gene regulation. This guide connects biochemical potency, cell-based assay design, formulation, and in vivo pharmacokinetic evidence.
-
AZD1390: ATM Kinase Inhibitor Workflow
2026-08-28
AZD1390 enables mechanism-led ATM inhibition in radiation, replication-stress, and glioblastoma models. Its strongest differentiation is the ability to connect DNA damage response signaling with emerging REV1–DHX36 and G-quadruplex biology while preserving a practical, concentration-controlled workflow.
-
STMN2 Depletion, Translation Deficits, and ALS Stress
2026-08-28
The reference study shows that neuronal STMN2 depletion can arise through proteasomal degradation, phosphorylation, stress-granule-associated translation repression, and chronic translation deficits, even without TDP-43 splicing failure. Its findings connect STMN2 protein instability with neuronal stress vulnerability and identify mRNA upregulation as a possible compensatory response in selected ALS contexts.
-
Tacalcitol Monohydrate: VDR and NGF Research
2026-08-27
Tacalcitol monohydrate is a synthetic analog of vitamin D3 that activates VDR-directed transcription in dermatology and colorectal cancer research. Published cell studies link tacalcitol with CDKN1A induction, thymidylate synthase reduction, NGF induction, and increased 5-fluorouracil sensitivity.
-
LCN2, Ferroptosis, and SA-AKI: AMPK/SIRT3/FOXO3a
2026-08-27
This study identifies Lipocalin-2 (LCN2) as a potential promoter of renal ferroptosis in sepsis-associated acute kidney injury through suppression of the AMPK/SIRT3/FOXO3a antioxidant pathway. By combining CLP-induced sepsis, LPS-stimulated HK−2 cells, genetic manipulation, and pathway rescue experiments, the work connects an established injury biomarker with a testable mechanism of oxidative renal damage.
-
Biotin (Vitamin B7) for STING Assay Design
2026-08-26
Biotin (Vitamin B7) connects rigorous affinity-based detection with modern innate-immunity experiments. This article translates shrimp STING findings into practical decisions for protein labeling, nucleic-acid sensing assays, controls, and reagent handling.
-
Shrimp STING Reveals an Ancestral DNA-Sensing Axis
2026-08-26
Li and colleagues show that shrimp STING can bind both cytosolic double-stranded DNA and cyclic dinucleotides, extending the known functions of this innate immune adaptor beyond mammalian cGAS–STING models. The study connects nucleic-acid sensing to IKKε, IRF activation, Vago4 induction, and an antiviral state, providing evidence for an evolutionarily conserved DNA-responsive pathway in an arthropod.